Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age

Clinical trial NCT05630859 · COMPLETED

Trial details

NCT number: NCT05630859
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sexually Transmitted Diseases

Start date: 2022-11-28
Primary completion: 2025-05-22
Enrollment: 1009

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.